122-132 Yangwan Road
Jingmen 448000
China
86 27 6565 1730
https://www.biocause.com
Sector(s): Financial Services
Industry: Insurance - Life
Full-time employees: 1,765
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Ms. Wenxia Zhou | Vice Chairman & GM | N/A | N/A | 1972 |
Mr. Dali Chen | CFO & Director | N/A | N/A | 1962 |
Mr. Fei Long | Secretary of the Board & Non-Independent Director | N/A | N/A | 1979 |
Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. It also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, the company is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. It exports its products to approximately 85 countries, including the United States, the European Union, and internationally. The company is based in Jingmen, China.
Hubei Biocause Pharmaceutical Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.